| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 74 |
| 1 | ACETAMINOPHEN | 69 |
| 2 | LAMOTRIGINE | 67 |
| 3 | GABAPENTIN | 66 |
| 4 | ATENOLOL | 64 |
| 5 | NIFEDIPINE | 64 |
| 6 | PROPRANOLOL HYDROCHLORIDE | 64 |
| 7 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 62 |
| 8 | DIMENHYDRINATE | 62 |
| 9 | NAPROXEN SODIUM | 61 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FROVATRIPTAN SUCCINATE | 55 | 0.0689 |
| 1 | DIHYDROERGOTAMINE MESYLATE | 40 | 0.0297 |
| 2 | VERAPAMIL HYDROCHLORIDE | 35 | 0.0081 |
| 3 | RIZATRIPTAN BENZOATE | 61 | 0.0059 |
| 4 | DIMENHYDRINATE | 62 | 0.0058 |
| 5 | CASTOR OIL | 1 | 0.0052 |
| 6 | TETRACAINE | 2 | 0.0051 |
| 7 | FOSFOMYCIN TROMETHAMINE | 3 | 0.0049 |
| 8 | BOTULINUM TOXIN TYPE A | 59 | 0.0046 |
| 9 | ALLOPURINOL SODIUM | 2 | 0.0035 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 87 |
| 1 | Corticosteroid [EPC] | 86 |
| 2 | Dihydropyridine Calcium Channel Blocker [EPC] | 72 |
| 3 | Anti-epileptic Agent [EPC] | 67 |
| 4 | Mood Stabilizer [EPC] | 67 |
| 5 | beta-Adrenergic Blocker [EPC] | 65 |
| 6 | Expectorant [EPC] | 63 |
| 7 | Acetylcholine Release Inhibitor [EPC] | 60 |
| 8 | Central alpha-2 Adrenergic Agonist [EPC] | 60 |
| 9 | Neuromuscular Blocker [EPC] | 60 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 1 | Phenothiazine [EPC] | 55 | 0.0018 |
| 2 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 3 | Central alpha-2 Adrenergic Agonist [EPC] | 60 | 0.0011 |
| 4 | Non-Standardized Fungal Allergenic Extract [EPC] | 2 | 0.0009 |
| 5 | Plasma Volume Expander [EPC] | 2 | 0.0006 |
| 6 | Acetylcholine Release Inhibitor [EPC] | 60 | 0.0006 |
| 7 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 8 | Antiseptic [EPC] | 2 | 0.0005 |
| 9 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |